66) erstood, which hinders the development of new therapies. |
67) ;1 year, highlighting the urgent need for new therapies. |
68) orth America (n = 6), Europe (n = 6), and New Zealand (n = 1). |
69) The USA (n = 7), New Zealand (n = 4), Canada (n = 3), t |
70) er colonial countries (Australia, Canada, New Zealand and USA). |
71) tantially ahead of Canada, Australia, and New Zealand in AIR-PA research. |
72) the UK, Europe, Asia, USA, Australia and New Zealand. |
73) , with half originating from Australia or New Zealand. |
74) on residualized values and show that this new approach corrects for the observed bia |
75) Furthermore, this new approach has enabled nutrition researc |
76) development lays the groundwork for using new approach methodologies (NAMs) to evalu |
77) rapeutic inhibition of miR-132 might be a new approach to alleviate liver fibrosis, |
78) We present a new approach to compute and analyze the dy |
79) This study reports a new approach to use therapeutic ultrasound |
80) ocessing health data is essential for the new diagnostic and decisional technologies |
81) ic cancer foci, and nanoparticles brought new diagnostic and therapeutic options. |
82) itiative on Malnutrition (GLIM), defining new diagnostic criteria for malnutrition, |
83) to Mycobacterium tuberculosis can provide new diagnostic insights into not only the |
84) Furthermore, a new diagnostic model for ESCC based on ser |
85) Thus, there is a need to develop new diagnostic tools to facilitate early d |
86) dropped or graduated, the next available new treatment can be immediately added and |
87) ed AKI diagnosis in COVID-19 patients and new treatment options are required to redu |
88) at accurately evaluates the efficacy of a new treatment or drug. |
89) the development of preclinical testing of new treatment strategies. |
90) c and Nanog siRNA could be exploited as a new treatment strategy to improve the canc |
91) from two studies: (1) a study comparing a new treatment to the standard of care in t |
92) Here, a new class of NIR-triggered in situ gelatio |
93) nclude that EU1794-4 is a prototype for a new class of NMDA receptor negative allost |
94) mall molecule Bak activator may provide a new class of anticancer agents to treat lu |
95) This work lays the foundation for a new class of hybrid computational approach |
96) trodes are critical steps in developing a new class of optobiological tools for neur |
97) Background: New data collection in established longitu |
98) New data suggest that the previous hypothe |
add keyword